Urology Research and Clinical Trials
The Department of Urology at Montefiore Medical Center places great emphasis on advancing the techniques and therapies for treating urologic diseases. We are involved in a wide spectrum of basic studies, translational studies and clinical studies.
Currently the department is conducting several prostate and kidney cancer clinical trials. And we are also investigating how robotic surgery compares to laparoscopic procedures.
We have expanded our research support staff and database of all cancer cases performed in our oncology division in an effort to better analyze our outcomes based on these radical procedures. Because many of these procedures are relatively new, the body of studies comparing them to traditional/open procedures is growing exponentially.
Unlike many similar research efforts at other institutions, all of our databases are structured so we can compare and contrast these procedures and their efficacy to the open standard operations performed at the same institution by the same surgeon.
We believe this offers a more accurate assessment of results instead of utilizing outcomes from nationwide studies to help our patients. This helps us critically assess our own experience so that we can advise patients, not solely based on the literature and other surgeons, but on our own years of experience which are all within the standards of excellence.
The department of Urology and specifically the Urologic Oncology Program has numerous clinical trials open for investigation of new strategies for the treatment of recurrent prostate cancer after radical prostatectomy and/or radiation therapy, BCG refractory bladder cancer and basic science investigations regarding the role of several compounds at the molecular level and their roles in aggressive prostate cancer and its progression and recurrence.
Finally, we are actively conducting outcomes research in helping us elucidate barriers to education and knowledge regarding prostate cancer treatment decision making processes and also the epidemiology of prostate cancer in the inner city urban population centers.